Pre-treatment serum lactate dehydrogenase level is an important prognostic factor in high-grade extremity osteosarcoma

Clinical and Translational Oncology

Volumn 11, Issue 7, 2009, Pages 479-483

  González Billalabeitia, Enrique ^a,c   Hitt, Ricardo ^a   Fernández, Jesús ^b   Conde, Esther ^b   Martínez Tello, Francisco ^b   De Salamanca, Rafael Enríquez ^a   Cortés Funes, Hernán ^a  

^a University Hospital   (Spain)

^b University Hospital   (Spain)

^c HOSPITAL MORALES MESEGUER   (Spain)

Author keywords

Lactate dehydrogenase; Osteosarcoma; Prognosis

Indexed keywords

LACTATE DEHYDROGENASE;

ADOLESCENT; ADULT; ARTICLE; BLOOD; BONE TUMOR; CANCER STAGING; CHILD; DISEASE FREE SURVIVAL; FEMALE; HUMAN; MALE; MIDDLE AGED; OSTEOSARCOMA; PATHOLOGY; PRESCHOOL CHILD; PROGNOSIS;

ADOLESCENT; ADULT; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; L-LACTATE DEHYDROGENASE; MALE; MIDDLE AGED; NEOPLASM STAGING; OSTEOSARCOMA; PROGNOSIS;

EID: 73349086554     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-009-0388-9     Document Type: Article

References (38)

1. Stillera CA, Bielack SS, Jundt G, Steliarova-Fouchere E (2006) Bone tumours in European children and adolescents, 1978-1997. Report from the Automated Childhood Cancer Information System project. Eur J Cancer 42:2124-2135
2. Jemal A, Siegel R, Ward E et al (2008) Cancer statistics 2008. CA Cancer J Clin 58:71-96
3. Dahlin DC (1978) Bone tumors: General aspects and data on 6221 cases, 3rd Edn. Charles C Thomas, Springfield, IL
4. Lichtenstein L (1977) Bone tumors, 5th Edn. Mosby, St Louis, MO
5. Jaffe HL (1958) Tumors and tumorous conditions of the bone and joints. Lea & Febiger, Philadelphia
6. Malawer MM, Link MP, Donaldson SS (2004) Sarcomas of bone. Cancer, principles and practice of oncology, 6th Edn. Lippincott Williams and Wilkins, Philadephia, PA pp 1981-1995
7. Weingard DN, Rosenberg SA (1978) Early lymphatic spread of osteogenic and soft tissue sarcomas. Surgery 84:231-240
8. Enneking WF, Spanier SS, Goodman MA (1980) A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop 153:106-115
9. Marcove RC, Rosen G (1980) En bloc resection for osteogenic sarcoma. Cancer 45:3040-3044
10. Malawer MM (1983) Distal femoral osteogenic sarcoma, principles of soft tissue resection and reconstruction in conjunction with prosthetic replacement (adjuvant surgery). In: Chao EYS (ed.) Design and application of tumor prosthesis for bone and joint reconstruction. Thieme-Stratton, New York, pp 297-308
11. Enneking WF, Dunham WK (1978) Resection and reconstruction for primary neoplasms involving the innominate bone. J Bone Joint Surg Am 60: 731-746
12. Rosen G, Marcove RC, Caparros B et al (1979) Primary osteogenic sarcoma. The rationale for preoperative chemotherapy and delayed survey. Cancer 43:2163-2177
13. Muggia F, Catani R, Lee YJ et al (1979) Factors responsible for therapeutic success in osteosarcoma. In: Jones S, Salmon S (eds) Adjuvant therapy for cancer, 2nd Edn. Grune & Stratton, New York
14. Cortes EP, Holland JP (1981) Adjuvant therapy for primary osteogenic sarcoma. Surg Clin North Am 61:1391-1398
15. Link MP (1986) Adjuvant therapy in the treatment of osteosarcoma. In: DeVita VT, Hellman S, Rosenverg SA (eds) Important advances in oncology. JB Lippincott, Philadelphia, pp 193-194
16. Link MP, Goorin AM, Miser AW et al (1986) The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med 314:1600-1605
17. Eilber F, Guiliano A, Eckardt J et al (1987) Adjuvant chemotherapy for osteosarcoma . a randomized prospective trial. J Clin Oncol 5:21-26
18. Rosen G, Caparrol B, Huvos AC et al (1982) Preoperative chemotherapy for osteogenic sarcoma: Selection of postoperative adjuvant chemotherapy based upon the response of the primary tumor to preoperative cancer. Cancer 49:1221-1230
19. Ferrari S, Smeland S, Mercuri M et al (2005) Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: A joint study by the Italian and Scandinavian Sarcoma Groups. J Clin Oncol 23:8845-8852
20. Bielack SS, Kempf-Bielack B, Delling G et al (2002) Prognostic factors in high-grade osteosarcoma of the extremities or trunk: An analysis of 1702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 20:776-790
21. Ger LP, Wang JW, Lin CC, Wang J (1993) Prognostic factors in 43 cases of osteosarcoma. J Formos Med Ass 92:962-968
22. Lopez Aguilar E, Rivera Márquez H, Cerecedo Díaz F et al (1996) Láctico dehidrogenasa como factor pronóstico en el desarrollo de enfermedad pulmonar metastásica en pacientes con osteosarcoma. Gac Med Mex 132:363-366
23. Pochanugool L, Subhadharophandou T, Danachai M et al (1997) Prognostic factors among 130 patients with osteosarcoma. Clin Orthop Relat Res 345:206-214
24. Goorin AM, Schwartzentruber DJ, Devidas M et al (2003) Presurgical chemotherapy with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group study POG-8651. J Clin Oncol 21:1574-1580
25. Bacci G, Ferrari S, Sangiorgi L et al (1994) Prognostic significance of serum lactate dehydrogenase in patients with osteosarcoma of the extremities. J Chemother 6:204-210
26. Bacci G, Longhi A, Ferrari S et al (2004) Prognostic significance of serum lactate dehydrogenase in osteosarcoma of the extremity: Experience at Rizzoli on 1421 patients treated over the last 30 years. Tumori 90:478-484
27. Meyers PA, Heller G, Healey J et al (1992) Chemotherapy for nonmetastatic osteogenic sarcoma: The Memorial Sloan-Kettering experience. J Clin Oncol 10:5-15
28. Rosen G, Murphy ML, Huvos AG et al (1976) Chemotherapy, en bloc resection and prosthetic bone replacement in the treatment of osteogenic sarcoma. Cancer 37:1-11
29. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481
30. Mantel M (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170
31. Cox DR (1972) Regression models and life-tables. J R Stat Soc 34:187-220
32. Walenta S, Mueller-Klieser WF (2004) Lactate: Mirror and motor of tumor malignancy. Semin Radiat Oncol 14:267-274
33. Albain KS, Crowley JJ, LeBlanc M, Livingston RB (1990) Determinants of improved outcome in small-cell lung cancer: An analysis of the 2580 patient Southwest Oncology Group database. J Clin Oncol 9:1563-1574
34. Tas F, Aykan F, Alici S et al (2001) Prognostic factors in pancreatic carcinoma: Serum LDH levels predict survival in metastatic disease. Am J Clin Oncol 24:547-550
35. Kemeny N, Braun DW (1983) Prognostic factors in advanced colorectal carcinoma. Importance of lactic dehydrogenase level, performance status, and white blood cell count. Am J Med 74:786-794
36. Smaletz O, Scher HI, Small EJ et al (2002) Nomogram for overall survival of patients with progressive metastatic prostate cancer after castration. J Clin Oncol 20:3972-3982
37. Garcia R, Hernandez JM, Caballero MD et al (1993) Serum lactate dehydrogenase level as a prognostic factor in Hodgkin's disease. Br J Cancer 68:1227-1231
38. Bacci G, Ferrari S, Longhi A et al (1999) Prognostic significance of serum LDH in Ewing's sarcoma of bone. Oncol Rep 6:807-811